Omega Diagnostics Announces Top-Level Management Shift
Company Announcements

Omega Diagnostics Announces Top-Level Management Shift

Omega Diagnostics (GB:CNSL) has released an update.

Cambridge Nutritional Sciences plc (CNSL) has announced a significant change in leadership as James Cooper, the former COO, steps in as the interim CEO following Jag Grewal’s resignation after 13 years with the company. Grewal, who has been credited with steering the company’s shift from infectious disease diagnostics, will assist in a smooth transition. The board expresses confidence in Cooper’s capabilities and gratitude towards Grewal for his contributions to the company’s development and growth.

For further insights into GB:CNSL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskOmega Diagnostics Announces AGM and Report
TipRanks UK Auto-Generated NewsdeskOmega Diagnostics Grants Share Options to COO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App